| Primary |
| Product Used For Unknown Indication |
67.2% |
| Ill-defined Disorder |
14.9% |
| Cardiac Failure |
6.0% |
| Neuralgia |
4.5% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Hypertension |
1.5% |
|
| Hypersensitivity Vasculitis |
16.7% |
| Leukocytoclastic Vasculitis |
16.7% |
| Lung Disorder |
16.7% |
| Renal Failure Acute |
16.7% |
| Hypogammaglobulinaemia |
8.3% |
| Lung Infection |
8.3% |
| Rash Generalised |
8.3% |
| Reading Disorder |
8.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
39.7% |
| Product Used For Unknown Indication |
24.0% |
| Hypertension |
6.0% |
| Diabetes Mellitus |
3.7% |
| Bronchitis |
3.0% |
| Osteitis |
3.0% |
| Anxiety |
2.6% |
| Back Pain |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Gastritis |
1.9% |
| Depression |
1.5% |
| Hyperlipidaemia |
1.5% |
| Prostate Cancer |
1.5% |
| Arrhythmia |
1.1% |
| Atrial Fibrillation |
1.1% |
| Gastric Ulcer |
1.1% |
| Prophylaxis |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Alcoholism |
0.7% |
| Angina Pectoris |
0.7% |
|
| Thrombocytopenia |
18.0% |
| Toxic Skin Eruption |
10.0% |
| Lung Disorder |
8.0% |
| Pruritus |
8.0% |
| Hypogammaglobulinaemia |
6.0% |
| Weight Decreased |
6.0% |
| Interstitial Lung Disease |
4.0% |
| Prothrombin Level Decreased |
4.0% |
| Pruritus Generalised |
4.0% |
| Pulmonary Fibrosis |
4.0% |
| Rash Maculo-papular |
4.0% |
| Tuberculosis |
4.0% |
| Vascular Purpura |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Eosinophilic Fasciitis |
2.0% |
| Gout |
2.0% |
| Haemolytic Anaemia |
2.0% |
| Hypersensitivity Vasculitis |
2.0% |
| Hypotonia |
2.0% |
| Jaundice Cholestatic |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.8% |
| Product Used For Unknown Indication |
19.0% |
| Rheumatoid Arthritis |
7.4% |
| Unevaluable Event |
5.6% |
| Ill-defined Disorder |
5.1% |
| Hypertension |
4.7% |
| Hepatitis C |
4.0% |
| Psoriatic Arthropathy |
3.8% |
| Prophylaxis |
3.5% |
| Depression |
3.0% |
| Lung Infection |
3.0% |
| Pain |
3.0% |
| Neuralgia |
2.7% |
| Hiv Infection |
2.4% |
| Insomnia |
2.4% |
| Pyelonephritis Acute |
2.2% |
| Atrial Fibrillation |
2.0% |
| Cardiac Failure |
1.7% |
| Lung Neoplasm Malignant |
1.5% |
| Back Pain |
1.3% |
|
| Vomiting |
10.0% |
| Renal Failure Acute |
9.1% |
| Stevens-johnson Syndrome |
9.1% |
| Somnolence |
7.3% |
| Malaise |
5.5% |
| Renal Failure |
5.5% |
| Pain In Extremity |
4.5% |
| Pulmonary Fibrosis |
4.5% |
| Respiratory Distress |
4.5% |
| Weight Decreased |
4.5% |
| Cholestasis |
3.6% |
| Gamma-glutamyltransferase Increased |
3.6% |
| Hyponatraemia |
3.6% |
| Jaundice |
3.6% |
| Renal Failure Chronic |
3.6% |
| Renal Neoplasm |
3.6% |
| Thrombocytopenia |
3.6% |
| Transaminases Increased |
3.6% |
| Urinary Tract Infection |
3.6% |
| Carbon Monoxide Diffusing Capacity Decreased |
2.7% |
|
| Interacting |
|
| Hypogammaglobulinaemia |
25.0% |
| International Normalised Ratio Increased |
25.0% |
| Lung Disorder |
25.0% |
| Pneumonia |
25.0% |
|
